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The Significance of Thyroid Hormone Transporters in
the Brain
The developing brain is an important target of thyroid
hormones. A complex regulatory network involving transfer
of thyroid hormones through the brain barriers, interactions
between neurons and glial cells, and deiodinase expression,
works to deliver the appropriate amount of T3 to the nuclear
receptors. The data provided by Heuer et al. (1) in this issue
indicates that specific thyroid hormone transporters may
also be an essential part of this regulatory system.
Thyroid hormones influence brain development from
about the end of the first trimester of fetal life. The human
fetal brain expresses nuclear T3 receptors at least from the
10th week of gestation, and receptor concentration increases
10-fold during the second trimester in brain and other tissues
(2). T4 is present in brain and other tissues, such as liver,
kidney, and lung, but T3 is detectable only in brain, at con-
centrations that result in an occupancy of brain T3 receptors
around 25%. The source of T4 reaching the fetal brain up to
midgestation is mostly of maternal origin (3). Both T4 and T3
cross the placenta and reach the fetal organs, but only T4
appears to cross the fetal blood-brain barrier. Thus, the ad-
ministration of T3 by constant infusion to pregnant rat dams
increased T3 concentrations in all maternal and fetal tissues
except the fetal brain (4). In contrast, the administration of T4
increased T3 content in fetal brain as well as in other tissues.
Therewas also a very important difference between the brain
and the rest of the tissues. When increasing amounts of T4
were administered to pregnant dams maintained on me-
thimazole, normal concentrations of T3 in the fetal brainwere
kept over a much wider range of T4 doses than in other
tissues.
In adult rats, both T4 and T3 reach the brain from blood,
but it was estimated that as much as 80% of the T3 bound to
the nuclear receptors was produced locally by type 2 deio-
dinase (D2) activity (5). As in fetal brain, when either T4 or
T3 was administered to hypothyroid rats, the T3 content of
the brain was maintained within control values only by T4,
but not by T3, infusion (6). Homeostasis of T3within the brain
is maintained within narrow limits by a complex mechanism
involving D2 and D3. Several years ago we reported that D2
was predominantly expressed in glial cells of two types,
tanycytes and astrocytes (7) (Fig. 1). Tanycytes, in which
expression of D2 was also reported by Tu et al. (8), are
specialized ependymal cells lining the third ventricle and
extending processes to the adjacent hypothalamus and the
median eminence. The T3 generated by these cells from ce-
rebrospinal T4 could play a role in TRH-TSH regulation. On
the other hand, expression of D2 in the astrocytes suggested
to us the existence of interplay between astrocytes and neu-
rons on T3 homeostasis similar to the metabolic coupling
between the two cells concerning the glutamate-glutamine
cycle or glucose use (9). Astrocytes would produce T3 for
neuronal use. As an additional control of neuronal T3 con-
centration, D3, which degrades T3 to the inactive metabolite
diiodothyronine, is expressed in neurons. In this issue,Heuer
et al. (1) confirm expression of D2 in the astrocytes and
suggest important roles in T3 homeostasis for recently char-
acterized thyroid hormone transporters (Fig. 1).
The entry of thyroid hormones into the cells has for a long
time been assumed to be by passive diffusion, because thy-
roid hormones are lipophilic molecules and as such could
easily enter the membrane lipid bilayer. Experiments in vivo
hardly gave any hint of a saturable process, as was, for
example, the binding of T3 to the nucleus, an observation that
facilitated the discovery of nuclear receptors. However, in
isolated hepatocytes and other cell types, the demonstration
of relatively high-affinity sites for both T4 and T3, and the
inhibition of cellular uptake by metabolic inhibitors, amino
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FIG. 1. Thyroid hormones are transported through the blood-brain
barrier (OATP) or the blood-CSF barrier (OATP and MCT8). In the
astrocytes and tanycytes T4 is converted to T3 which then enters the
neurons through MCT8. In the neurons both T4 and T3 are degraded
by D3. T3 from the tanycytes may reach the portal vessels in the
median eminence.Other transportersmay be present on the astrocyte
or tanycyte membranes. In most cases the transport could be bidi-
rectional, although only one direction is shown.
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acids, and other chemicals, gave evidence for the physiolog-
ical significance of thyroid hormone transporters (10). Sev-
eral molecular entities have been identified as transporters
for thyroid hormone (11). They belong to threemain families:
the organic anion-transporting polypeptides (OATP), the L-
amino acid transporters, and the monocarboxylate anion
transporters (MCT).
Among the many members of the OATP family, human
OATP-F (12) and rat Oatp14 (13) are preferentially expressed
in brain. TheOatp14 protein is localized in the border of brain
capillary endothelial cells and in the choroid plexus. OATP-
F/Oatp14 transports T4 and rT3 much more efficiently than
T3, and might be involved in the transport of T4 through the
blood-brain barrier and through the choroid plexus, and also
in rT3 clearance. The blood-brain barrier is the route bywhich
thyroid hormone is preferentially distributed throughout the
brain, and this transporter could facilitate uptake of T4 by the
astrocytes. Transfer of thyroid hormone through the choroid
plexus achieves only limited diffusion to the brain paren-
chyma after passage to the cerebrospinal fluid but would
allow uptake of T4 by tanycytes and subsequent T3 genera-
tion in these cells.
The MCT family comprises up to 14 members, some of
which are involved in the transport of important substrates
for the brain such as lactate and pyruvate. MCT8 has been
shown to act as a specific transporter for T4 and T3 and
displays slightly higher affinity for T3 (14). Heuer et al. (1)
have also studied the regional expression of MCT8 mRNA.
In addition to high expression levels in the choroid plexus,
they found that MCT8 is expressed in neurons of the neo-
cortex, hippocampus, basal ganglia, amygdala, hypothala-
mus, and the Purkinje cells of the cerebellum, all regions
known to be sensitive to thyroid hormones (15). Expression
of MCT8 in neurons suggests that neuronal uptake of the T3
produced in astrocytes is facilitated by this transporter.
The physiological significance ofMCT8 as a transporter for
thyroid hormone is supported by the finding of mutations in
humans by Dumitrescu et al. (16) and Friesema et al. (17). The
syndrome affects children from an early age and consists of
severe developmental delay and neurological damage to-
gether with an unusually altered pattern of thyroid hormone
levels in blood. The patients presented low total and free T4,
high total and free T3, and low rT3. TSH was moderately
elevated in two of the patients and normal or slightly ele-
vated in the other five. Inactivating mutations of the MCT8
transporter could result in the altered thyroid hormone lev-
els. In vitro uptake of T4 and T3 by fibroblasts isolated from
affected males was strongly reduced, and intracellular D2
was increased 6- to 8-fold (17). It is thus hypothesized that
the resulting increase in intracellularly generated T3 accu-
mulates in blood because of its poor reuptake into cells. In
addition, deficient uptake of T4 and T3 by neurons could
reduce degradation by neuronal D3 to rT3 and diiodothy-
ronine, respectively, with increased T3 and decreased rT3.
The brain and skin are predominant sites of D3 expression,
but their contribution to T3 degradation and to blood rT3 is
difficult to estimate (18).
The neurological syndrome caused by MCT8 mutations
consists of developmental delays, rotary nystagmus, severe
proximal hypotonia with poor head control, spastic quadri-
plegia, dystonicmovements, and impaired gaze and hearing.
More recently, a syndrome of paroxysmal dyskinesia has
been recognized by Brockmann et al. (19) in the two patients
originally described by Dumitrescu et al. (16). The whole
clinical picture is so severe that it is pertinent to ask the
question of whether the impaired uptake and action of thy-
roid hormone on neurons could cause such a syndrome. The
neurological disorder of endemic cretinism (neurological
cretinism) consists of variable degrees of neuromotor affec-
tationwith proximal limb girdle spasticity and rigidity, more
often affecting the lower extremities, extrapyramidal disor-
ders of rigidity and bradykinesia, deaf-mutism, strabismus,
dysarthria, and mental deficiency (20). Epidemiological and
physiopathological considerations indicate that this syn-
drome is most probably a result of lack of thyroid hormone
during fetal development, especially before midgestation.
This is the period of neuroblast proliferation and maturation
of the basal ganglia and cerebral cortex. In the postmortem
examination of the maternal uncle of one of the patients, also
probably affected, loss of neurons in the cerebral cortex, basal
ganglia, and cerebellum was found (16). As mentioned
above, the second trimester is also the period when thyroid
hormone receptors increase in concentration in the brain. If
MCT8 is needed at this stage of development for T3 entry into
neurons, mutations of the transporter could also interfere
with T3-dependent developmental processes. Knowledge of
the ontogenetic patterns of MCT8 in the human fetal brain
would certainly be helpful. On the other hand, there is also
the possibility that MCT8 mutations interfere with transport
of other substrates for brain metabolism that could be even
more important than T3 in determining the severity and out-
come of the syndrome. Other members of the family transport
metabolic substrates such as pyruvate and lactate, butMCT8 so
far appears to be specific for iodothyronines (14).
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